Category Archives: Ulcerative Colitis

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Seres Therapeutics (Nasdaq: MCRB), a leading microbiome therapeutics company, announced the presentation of its final 24-week data from the pivotal Phase 3 ECOSPOR III study evaluating SER-109, an investigational oral microbiome therapy for recurrent C. difficile infection (rCDI). The data presented today in a poster of distinction at Digestive Disease Week 2021 demonstrated that SER-109 significantly reduced recurrence rates compared to placebo over 24 weeks (21.3% vs Continue reading →

This article was originally published here BMC Surg. 2021 May 19;21(1):247. doi: 10.1186/s12893-021-01250-y Continue reading →

INDIANAPOLIS, May 22, 2021 /PRNewswire/ -- In a pre-specified analysis of the Phase 2 SERENITY study, Eli Lilly and Company's (NYSE: LLY) mirikizumab improved fatigue in patients with moderately to severely active Crohn's disease (CD) at 12 weeks, as measured by the mean change in FACIT-Fatigue scores compared to placebo, with improvements that were sustained up to one year. These results are being presented virtually at Digestive Disease Week (DDW), May 21-23, 2021. Mirikizumab is being studied for UC and CD, two forms of inflammatory bowel disease that can cause serious and debilitating symptoms, and disruptions in daily life. Continue reading →

The comprehensive analysis of the Ulcerative Colitis Drug market assists businesses in gaining a competitive advantage and helps them reach their business goals and objectives. The global Ulcerative Colitis Drug market research report is formulated with the descriptive profiles of the leading companies of the market along with their pricing analysis, gross revenue, financial standing, sales network and distribution channel, profit margins, and market position Continue reading →

The US consumes more added sugar than any other country in the world. But in a country where sugar is added to many of our foods, it can be hard to track your intake. Continue reading →

Any travel requires some planning, especially if youre going camping, hiking, or doing other activities outdoors. When you have ulcerative colitis (UC), you need to think even more about where to go, what to pack, and how to find the nearest bathroom. Continue reading →

A recent study found that maintaining ulcerative colitis (UC) remission was significantly more common in patients who continued treatment with infliximab, compared to those who discontinued treatment. The use of anti-tumor necrosis factor (TNF) agents is common in the treatment of refractory UC, but the long-term use of anti-TNF therapy can increase the risk of malignancy or infection. Continue reading →

Deucravacitinib could soon be coming for a chunk of these. However, safety is still the big unknown for the Bristol project Continue reading →

"You're too young to be that sick." That is what my former gastroenterologist said to me when I was first diagnosed with ulcerative colitis sometime around 2000. Continue reading →

People who take a commonly-prescribed drug for inflammatory bowel disease (IBD) should not assume they are protected after a first dose of Covid-19 vaccine, say the authors of a large-scale study that found many had poor antibody responses. Continue reading →